NuCana plc NCNA | $884.19M | 4020.74 | 3.4M | -27.4% | -$333.68M | 1.84 | |
| Aerovate Therapeutics, Inc. AVTE | $111.14M | 13.05 | 3.76M | 0% | +$0 | 0.23 | |
| NextCure, Inc. NXTC | $5.96M | 9.55 | 2.67M | 0% | +$0 | 0.01 | |
Bolt Biotherapeutics, Inc. BOLT | $3.86M | 7.22 | 2.75M | 0% | +$0 | 0.01 | |
| Inozyme Pharma, Inc. INZY | $32.79M | 6.92 | 4.28M | 0% | +$0 | 0.07 | |
| Vera Therapeutics, Inc. VERA | $120.48M | 5.11 | 2.79M | -19.42% | -$29.03M | 0.25 | |
ArriVent BioPharma, Inc. Common Stock AVBP | $30.3M | 5.07 | 1.7M | New | +$30.3M | 0.06 | |
| Y-mAbs Therapeutics, Inc. YMAB | $35.68M | 5 | 2.19M | 0% | +$0 | 0.07 | |
| Achieve Life Sciences, Inc. ACHV | $6.9M | 4.42 | 1.52M | New | +$6.9M | 0.01 | |
| Silk Road Medical, Inc SILK | $21.78M | 3.01 | 1.19M | New | +$21.78M | 0.05 | |
| Marinus Pharmaceuticals, Inc. MRNS | $12.67M | 2.55 | 1.4M | -20.96% | -$3.36M | 0.03 | |
Cogent Biosciences, Inc. COGT | $16.13M | 2.51 | 2.4M | New | +$16.13M | 0.03 | |
Immatics N.V. IMTX | $22.74M | 2.1 | 2.16M | -27.13% | -$8.46M | 0.05 | |
Dyne Therapeutics, Inc. DYN | $54.98M | 1.98 | 1.94M | +91.08% | +$26.21M | 0.11 | |
| Syndax Pharmaceuticals, Inc. SNDX | $38.28M | 1.89 | 1.61M | +49.52% | +$12.68M | 0.08 | |
| Savara Inc. SVRA | $11.69M | 1.7 | 2.35M | -1.49% | -$177,158.52 | 0.02 | |
| PepGen Inc. PEPG | $7.4M | 1.55 | 503,624 | +2,086.06% | +$7.06M | 0.02 | |
Ascendis Pharma A/S ASND | $113.99M | 1.3 | 754,032 | 0% | +$0 | 0.24 | |
| TG Therapeutics, Inc. TGTX | $30.19M | 1.28 | 1.98M | New | +$30.19M | 0.06 | |
Natera, Inc. NTRA | $141.79M | 1.26 | 1.55M | 0% | +$0 | 0.3 | |
| Celldex Therapeutics, Inc. CLDX | $33.65M | 1.22 | 801,777 | -5% | -$1.77M | 0.07 | |
Pharvaris N.V. PHVS | $13.51M | 1.09 | 584,672 | +14.54% | +$1.72M | 0.03 | |
| IDEAYA Biosciences, Inc. IDYA | $34.3M | 1.03 | 781,596 | -46.42% | -$29.72M | 0.07 | |
| Immunome, Inc. IMNM | $14.67M | 0.99 | 594,396 | New | +$14.67M | 0.03 | |
| Cabaletta Bio, Inc. CABA | $7.33M | 0.89 | 429,746 | +0.08% | +$5,988.06 | 0.02 | |
| Kura Oncology, Inc. KURA | $10.71M | 0.66 | 501,940 | -69.89% | -$24.86M | 0.02 | |
| Incyte Corporation INCY | $75.61M | 0.59 | 1.33M | +347.51% | +$58.71M | 0.16 | |
| Elanco Animal Health Incorporated ELAN | $41.6M | 0.52 | 2.56M | +114.05% | +$22.17M | 0.09 | |
| Establishment Labs Holdings Inc. ESTA | $7.19M | 0.51 | 141,162 | +4,525.23% | +$7.03M | 0.02 | |
| Soleno Therapeutics, Inc. SLNO | $6.45M | 0.44 | 150,775 | +12,464.58% | +$6.4M | 0.01 | |
| 4D Molecular Therapeutics, Inc. FDMT | $6.31M | 0.38 | 198,186 | New | +$6.31M | 0.01 | |
| Insulet Corporation PODD | $37.74M | 0.31 | 220,203 | +1,058.96% | +$34.49M | 0.08 | |
| Axonics, Inc. AXNX | $10.3M | 0.29 | 149,385 | New | +$10.3M | 0.02 | |
argenx SE ARGX | $58.78M | 0.25 | 149,300 | +233.85% | +$41.17M | 0.12 | |
| Sarepta Therapeutics, Inc. SRPT | $29.45M | 0.24 | 227,488 | New | +$29.45M | 0.06 | |
Fusion Pharmaceuticals Inc. FUSN | $3.35M | 0.19 | 157,172 | +25.44% | +$679,532.35 | 0.01 | |
| Align Technology, Inc. ALGN | $31.31M | 0.13 | 95,478 | New | +$31.31M | 0.07 | |
| Roivant Sciences Ltd. ROIV | $10.56M | 0.12 | 1M | New | +$10.56M | 0.02 | |
| Exact Sciences Corporation EXAS | $15.85M | 0.12 | 229,481 | New | +$15.85M | 0.03 | |
ShockWave Medical, Inc. SWAV | $11.4M | 0.09 | 35,000 | New | +$11.4M | 0.02 | |
| IDEXX Laboratories, Inc. IDXX | $40.62M | 0.09 | 75,224 | New | +$40.62M | 0.08 | |
| Madrigal Pharmaceuticals, Inc. MDGL | $5.08M | 0.09 | 19,029 | New | +$5.08M | 0.01 | |
| Alnylam Pharmaceuticals, Inc. ALNY | $15.4M | 0.08 | 103,036 | New | +$15.4M | 0.03 | |
| Intuitive Surgical, Inc. ISRG | $56.22M | 0.04 | 140,880 | +10.96% | +$5.56M | 0.12 | |
AstraZeneca PLC AZN | $40.43M | 0.04 | 596,713 | -29.85% | -$17.2M | 0.08 | |
| Avantor, Inc. AVTR | $5.94M | 0.03 | 232,446 | New | +$5.94M | 0.01 | |
| Merck & Co., Inc. MRK | $85.94M | 0.03 | 651,299 | -24.09% | -$27.27M | 0.18 | |
| Boston Scientific Corporation BSX | $24.24M | 0.02 | 353,851 | +170.12% | +$15.26M | 0.05 | |
Novo Nordisk A/S NVO | $78.57M | 0.02 | 611,884 | New | +$78.57M | 0.16 | |
| Inhibrx, Inc. INBX | $45.54B | <0.01 | 1.3M | +68.53% | +$18.52B | 94.74 |